Hepatomegaly
Showing 1 - 25 of 581
BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of
Recruiting
- BCR-JAK2 Fusion Protein Expression
- +11 more
-
Palo Alto, California
- +3 more
Oct 5, 2022
Biomarker for Farber Disease (BioFarber)
Active, not recruiting
- Farber's Lipogranulomatosis
- +3 more
-
Cairo, Egypt
- +2 more
May 17, 2021
Biomarker for Sly Disease (MPS VII) (BioSly)
Active, not recruiting
- Developmental Delay
- +3 more
-
Cairo, Egypt
- +4 more
May 12, 2021
Congenital Cytomegalovirus Infection Trial in Nancy
Completed
- Congenital Cytomegalovirus Infection
-
Nancy, FranceMaternity Hospital CHRU
Feb 22, 2023
Hepatomegaly, Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis
Terminated
- Hepatomegaly
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 23, 2019
Chronic Portal Vein Thrombosis in Children
Not yet recruiting
- Portal Vein Thrombosis
- endoscopy
- (no location specified)
Nov 3, 2023
Cirrhotic Patients With and Without Hepatocellular Carcinoma
Not yet recruiting
- Pulmonary Complications of Liver Cirrhosis and HCC
- spirometry
-
Sohag, EgyptSohag University hospitals
Jul 26, 2023
Hepatomegaly in Children and Type 1 Diabetes Mellitus
Unknown status
- Hepatomegaly
-
Assiut, EgyptAssiut children hospital
Sep 10, 2018
Mucopolysaccharidosis II Trial in Cincinnati (DNL310)
Enrolling by invitation
- Mucopolysaccharidosis II
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 10, 2023
Clinical Characteristics and Long-term Outcomes of Brucellosis
Completed
- Brucellosis
-
Huanggang, Hu Bei Province, China
- +7 more
Aug 17, 2023
Quality of Life in Thalassemic Patients at Assiut University
Not yet recruiting
- Thalassemia
- Abdominal ultrasound
- (no location specified)
Mar 17, 2023
Substances Potentially Indicating Bone Problems in Type 1
Not yet recruiting
- Gaucher Disease
- No Intervention
-
Zaragoza, Aragon, SpainFundación Española para el Estudio y Tratamiento de la Enfermeda
Jan 18, 2023
Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That
Not yet recruiting
- Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
- Inotuzumab Ozogamicin
- (no location specified)
Nov 3, 2022
Diet, Healthy, Obesity, Visceral, Bariatric Surgery Candidate Trial (With low-calorie, high-protein diet, Without low-calorie,
Not yet recruiting
- Diet, Healthy
- +2 more
- With low-calorie, high-protein diet
- Without low-calorie, high-protein diet
- (no location specified)
Jun 18, 2021
Glycogen Storage Disease Type IB Trial in Shanghai (Empagliflozin)
Recruiting
- Glycogen Storage Disease Type IB
-
Shanghai, Shanghai, ChinaXinhua Hospital, Shanghai Jiao Tong University School of Medicin
Jul 17, 2023
Adult-Onset Still's Disease, AOSD Trial in Moscow, St. Petersburg (RPH-104, Placebo)
Not yet recruiting
- Adult-Onset Still's Disease
- AOSD
- RPH-104
- Placebo
-
Moscow, Russian Federation
- +3 more
Jun 21, 2022
Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)
Terminated
- Chronic Lymphocytic Leukemia
-
Perugia, ItalyDepartment of Internal Medicine and Public Health, University of
Jan 18, 2022
The Polycystic Liver Disease Questionnaire (PLD-Q).
Recruiting
- Polycystic Liver Disease
- PLD-Q
-
Rochester, MinnesotaMayo Clinic
Nov 15, 2022
Patent Ductus Arteriosus Trial (Paracetamol, Ibuprofen)
Not yet recruiting
- Patent Ductus Arteriosus
- (no location specified)
Nov 22, 2023
Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Idelalisib, Obinutuzumab)
Completed
- Chronic Lymphocytic Leukemia
- Tirabrutinib
- +2 more
-
Frankfurt, Brandenburg, Germany
- +13 more
Dec 24, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 24, 2022
Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Entospletinib, Obinutuzumab)
Completed
- Chronic Lymphocytic Leukemia
- Tirabrutinib
- +2 more
-
Aschaffenburg, Germany
- +14 more
Dec 17, 2021
s After Very Low and Bariatric Surgery
Completed
- Diabetes Mellitus
- Ketoacidosis
-
Fitzroy, Victoria, AustraliaSt Vincent's Hospital Melbourne
Jun 29, 2022
Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)
Not yet recruiting
- Advanced Systemic Mastocytosis
- (no location specified)
Nov 2, 2022